Device Trial Radar · NCT05371535
A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone Graft
Last checked: Nov 20, 2026Latest source record: May 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
188
Planned (sponsor's estimate)
Start
May 30, 2022
Primary completion
Nov 30, 2022
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- Collagen MatrixNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 12, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this clinical trial is to evaluate the efficacy and safety of MatrixOssTM Bone Graft in bone defect repair caused by tooth extraction.
Conditions
- Dental Diseases
Interventions
MatrixOssTM Bone Graft plus Bio-Gide membraneDevice
To verify the efficacy and safety of MatrixOssTM Bone Graft developed and manufactured by Collagen Matrix, Inc. for bone defect repair caused by tooth extraction.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in alveolar ridge height from baseline to 24 weeks postoperative.Time frame: 24 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.